MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202621003813 A) filed by Dr. Rashmi Sapkal; Dr. Aqsa Tamboli; Dr. Komal Khedkar; Dr. Anagha Shete; Dr. Pallavi Prakash Channe; and Dr. Aishwarya Kamat on January 14, 2026, for A Method For Targeted Intralesional Drug Delivery For Controlled Treatment Of Oral Submucous Fibrosis.
Inventors include Dr. Rashmi Sapkal; Dr. Aqsa Tamboli; Dr. Komal Khedekar; Dr. Anagha Shete; Dr. Pallavi Prakash Channe; and Dr. Aishwarya Kamat.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: ABSTRACT Disclosed herein is a method for targeted intralesional drug delivery for controlled treatment of oral submucous fibrosis (...